Search results for "Contrast media"

showing 10 items of 323 documents

Imaging techniques in inflammatory bowel disease: recent trends, questions and answers

2009

Summary Imaging techniques have undergone substantial progress in recent years and contribute significantly in the diagnosis of inflammatory bowel diseases in conjunction with patient history, clinical and laboratory examination. Modern cross-sectional imaging modalities such as computed tomography and magnetic resonance imaging allow an evaluation not only of the complete bowel wall of the small intestine, but also of extraluminal structures. They constitute a major diagnostic component in the initial workup, in stricturing or fistulizing disease and in suspected abscess. Transabdominal ultrasonography has been re-appreciated in these settings as an easy- and ready-to-use tool yielding rea…

Diagnostic Imagingmedicine.medical_specialtyContrast MediaColonoscopySensitivity and SpecificityInflammatory bowel diseaseChromoendoscopyDiagnosis DifferentialCrohn DiseasePredictive Value of TestsmedicineEndomicroscopyHumansMedical historyClinical Trials as TopicMicroscopy Confocalmedicine.diagnostic_testbusiness.industryGastroenterologyMagnetic resonance imagingColonoscopyGeneral MedicineInflammatory Bowel Diseasesmedicine.diseaseMagnetic Resonance ImagingUlcerative colitisPositron emission tomographyPositron-Emission TomographyColitis UlcerativeRadiologyTomography X-Ray ComputedbusinessGastroentérologie Clinique et Biologique
researchProduct

Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy

2016

Focal nodular hyperplasia (FNH) is the second most common benign solid liver lesion after hemangioma, occurring more frequently in young women. The prime differential diagnoses include hepatocellular adenoma, hepatocellular carcinoma, and hypervascular metastasis. As the management of FNH is typically conservative, imaging plays a key role in diagnostic pathway, and misdiagnosis may have a major clinical effect. In this article, we describe the ultrasound, computed tomography, and magnetic resonance imaging features of FNH, underlining the importance of typical radiological features that allow a specific noninvasive diagnosis. We present a large spectrum of a typical imaging findings that F…

Diagnostic Imagingmedicine.medical_specialtyPathologyContrast Media030218 nuclear medicine & medical imagingDiagnosis DifferentialHemangioma03 medical and health sciences0302 clinical medicinemedicineMedical imagingHumansRadiology Nuclear Medicine and imagingMedical diagnosismedicine.diagnostic_testbusiness.industryFocal nodular hyperplasiaMagnetic resonance imagingHepatocellular adenomamedicine.diseaseFocal Nodular Hyperplasia030220 oncology & carcinogenesisHepatocellular carcinomaRadiologyDifferential diagnosisbusinessHumanSeminars in Ultrasound, CT and MRI
researchProduct

Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging

2013

Cardiac magnetic resonance (CMR) is considered an useful method in the evaluation of many cardiac disorders. Based on our experience and available literature, we wrote a document as a guiding tool in the clinical use of CMR. Synthetically we describe different cardiac disorders and express for each one a classification, I to IV, depending on the significance of diagnostic information expected.

Diagnostic informationmedicine.medical_specialtyContrast MediamedicineHumansRadiology Nuclear Medicine and imagingHeart; Mgnetic resonanceCardiac disordersCardiac imagingNeuroradiologymedicine.diagnostic_testbusiness.industryHeartMagnetic resonance imagingInterventional radiologyGeneral MedicineMagnetic Resonance ImagingItalyMagnetic resonanceCardiovascular Diseasescardiovascular systemRadiologyheart; magnetic resonanceSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessNuclear medicineCardiac magnetic resonanceMgnetic resonanceLa radiologia medica
researchProduct

FOCAL LIVER LESIONS: CONTRAST-ENHANCED ULTRASOUND

2008

Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in sonography and it is being increasingly used for evaluation of focal liver lesions (FLLs). The unique feature of CEUS of non-invasively assessing in real time liver perfusion throughout the vascular phase has led to a dramatic improvement in diagnostic accuracy of US in either detection and characterization of FLLs, as well as in the guidance and evaluation of response of therapeutic procedures. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, resulting in a better patient management and cost-effective therapy delivering. After a brief description of the basis of different CEUS tec…

Echinococcosis HepaticLiver perfusionmedicine.medical_specialtyUrologyLiver AbscessClinical settingsDiagnostic accuracySensitivity and SpecificityLiver neoplasmAdenoma Liver CellLiver diseaseInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingUltrasonography Doppler ColorUltrasound contrast mediaRadiological and Ultrasound TechnologyCystsbusiness.industryLiver DiseasesLiver NeoplasmsUltrasoundGastroenterologyUltrasonography DopplerGeneral MedicineHepatologyImage Enhancementmedicine.diseaseContrast-enhanced sonographyPatient managementFatty LiverFocal Nodular HyperplasiaUltrasonography Doppler PulsedRadiologyLiver sonographyHemangiomabusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaLiver diseaseContrast-enhanced ultrasound
researchProduct

Terminology for contrast-enhanced sonography: a practical glossary.

2007

Objective. The purpose of this glossary is to offer an updated guide to the correct terminology for contrast-enhanced sonography. Methods. This report was prepared by a panel of radiologists from the Sonography Section of the Italian Association of Medical Radiology. A leading author prepared a list of terms based on a comprehensive literature survey. The draft was analyzed by 3 experts on the topic of contrast-enhanced sonography. These reviewers reached a consensus and prepared the final version. Results. A list of 137 terms is included. These terms are briefly defined. Their proper application is discussed, with special reference to potential misleading uses. Conclusions. Contrast-enhanc…

Final versionmedicine.medical_specialtyPediatricsRadiological and Ultrasound TechnologyGlossarybusiness.industryContrast (statistics)Referring Physiciancontrast mediaTerminologyStandardized terminologycontrast-enhanced sonographyClinical PracticeMedicineRadiology Nuclear Medicine and imagingMedical physicsbusinessLiterature surveySettore MED/36 - Diagnostica Per Immagini E Radioterapiaultrasound terminology
researchProduct

The DAT ligand [(18)F]PR17.MZ mirrors the in vivo pharmacokinetic profile of [(11)C]cocaine with significantly improved monoamine transporter selecti…

2010

Fluorine RadioisotopesContrast MediaPharmacologyLigandsBiochemistryRats Sprague-DawleyPharmacokineticsCocaineIn vivoDrug DiscoverymedicineAnimalsBiogenic MonoaminesCarbon RadioisotopesGeneral Pharmacology Toxicology and PharmaceuticsDopamine transporterPharmacologyDopamine Plasma Membrane Transport ProteinsMonoamine transporterbiologymedicine.diagnostic_testChemistryOrganic ChemistryLigand (biochemistry)RatsBiochemistryPositron emission tomographyPositron-Emission Tomographybiology.proteinMolecular MedicineRadiopharmaceuticalsSelectivityChemMedChem
researchProduct

Ventilation-Perfusion Ratio in Perflubron During Partial Liquid Ventilation

2010

BACKGROUND: Functional magnetic resonance imaging (fMRI) of fluorine-19 allows for the mapping of oxygen partial pressure within perfluorocarbons in the alveolar space (Pao(2)). Theoretically, fMRI-detected Pao(2) can be combined with the Fick principle approach, i.e., a mass balance of oxygen uptake by ventilation and delivery by perfusion, to quantify the ventilation-perfusion ratio (Va/Q) of a lung region: The mixed venous blood and the inspiratory oxygen fraction, which are equal for all lung regions, are measured. In addition, the local expiratory oxygen fraction and the end capillary oxygen content, both of which may differ between the lung regions, are calculated using the fMRI-detec…

Fluorine RadioisotopesLiquid VentilationSwineContrast Mediachemistry.chemical_elementVentilation/perfusion ratioOxygenFick principleBody Temperaturechemistry.chemical_compoundVentilation-Perfusion RatioAnimalsHumansMedicineComputer SimulationFluorocarbonsbusiness.industryPerflubronHemodynamicsOxygen transportPartial pressureMagnetic Resonance ImagingHydrocarbons BrominatedOxygenPulmonary AlveoliAnesthesiology and Pain MedicinechemistryAnesthesiaBreathingPulmonary Diffusing CapacitybusinessNuclear medicineBlood Gas Monitoring TranscutaneousPerfusionAlgorithmsAnesthesia & Analgesia
researchProduct

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions : results of a mu…

2008

The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. To test for noninferiority the diagnostic accuracy rates for both contrast agents were compared with CT results based on a blinded reading. The average diagnostic accuracy across the three bli…

Gadobutrol; Gadopentate dimeglumine; Renal lesions; MRI; Diagnostic differentiation; NoninferiorityGadolinium DTPAMalemedicine.medical_specialtyContrast MediaRenal lesionsSensitivity and SpecificityGadobutrollaw.inventionGadobutrolPrecontrastRandomized controlled trialmagnetic resonance contrast medialawmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingSingle-Blind Methodddc:610Neuroradiologymedicine.diagnostic_testbusiness.industryDiagnostic differentiationUltrasoundReproducibility of ResultsMagnetic resonance imagingInterventional radiologyGeneral MedicineNoninferiorityMiddle AgedImage EnhancementMagnetic Resonance ImagingKidney NeoplasmsClinical trialEuropeRadiology Nuclear Medicine and imagingFemaleGadopentate dimeglumineRadiologybusinessNuclear medicinemedicine.drugMRI
researchProduct

Outcome of LR-3 and LR-4 observations without arterial phase hyperenhancement at Gd-EOB-DTPA-enhanced MRI follow-up

2020

Objective: The aim of this study was to retrospectively analyze the outcome of LR-3 and LR-4 without arterial phase hyperenhancement (APHE), and identify which features could predict LR-5 progression on serial Gd-EOB-DTPA-enhanced MRI follow-up. Methods: Forty-nine cirrhotic patients with 55 LR-3 and 19 LR-4 without APHE were evaluated. Observations were classified as decreased, stable or increased in category at follow-up. Observation size and LI-RADS major and ancillary features were evaluated. Results: Seventeen/fifty-five (31%) LR-3 and 8/19 (42%) LR-4 progressed to LR-5 at follow-up. Baseline LI-RADS major and ancillary features were not significantly different among LR-3 and LR-4. A d…

Gadolinium DTPAGd-EOB-DTPA-enhanced MRILR-3Carcinoma HepatocellularLR-4business.industryLiver NeoplasmsGd-EOB-DTPAContrast MediaMagnetic Resonance Imaging030218 nuclear medicine & medical imagingSettore MED/01 - Statistica Medica03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineHumansLI-RADSRadiology Nuclear Medicine and imagingNuclear medicinebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaArterial phaseFollow-Up StudiesRetrospective Studies
researchProduct

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

2015

Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.

Gadolinium DTPALiver CirrhosisGadoxetic acidCirrhotic livermedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisCarcinoma HepatocellularGadoxetic acidContrast MediaGastroenterology030218 nuclear medicine & medical imagingResection03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patientTopic HighlightSettore MED/12 - GastroenterologiaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyHepatobiliary contrast materialMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSettore MED/18 - Chirurgia GeneraleLiver030220 oncology & carcinogenesisHepatobiliary phaseLiver functionSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging; Gastroenterologymedicine.drugWorld journal of gastroenterology
researchProduct